Results 71 to 80 of about 28,857 (204)
Candidiasis vulvovaginal y factores de riesgo en mujeres de 20 a 49 años atendidas en el Puesto de Salud de Nuevo Horizonte, 2023 [PDF]
La presente investigación tuvo como objetivo determinar la Prevalencia y factores de riesgo de candidiasis vulvovaginal en mujeres de 20 a 49 años atendidas en el Puesto de Salud de Nuevo Horizonte, en el año 2023.
Quinde Pintado,Jhon Anthony +1 more
core +2 more sources
Gynecologic conditions in the context of incarceration: A scoping review
International Journal of Gynecology &Obstetrics, Volume 173, Issue 1, Page 117-137, April 2026.Abstract Background More than 740 000 people identified as female at intake were incarcerated globally as of 2022, reflecting a 60% global increase since the year 2000, with a concomitant increase in gynecologic conditions experienced behind bars.
Meredith K. Wise +6 more
wiley +1 more source
Vaginal azoles versus oral fluconazole in treatment of recurrent vulvovaginal candidiasis [PDF]
Background: Vulvovaginal candidiasis (VVC) is a fungal infection of the vagina and vulva. It is usually caused by Candida albicans, however, occasionally other candida species are responsible. The optimal treatment of VVC has not yet been defined.
فردی آذر, زهرا +3 more
core
Journal of International Medical ResearchObjectives Vulvovaginal candidiasis and its recurrent vulvovaginal candidiasis form place a significant burden on women worldwide. However, treatment options remain limited. Oteseconazole, a first-in-class tetrazole CYP51 inhibitor that received Food and
Yahya Samadi +13 more
doaj +1 more source
Treatment of recurrent vulvovaginal candidiasis in women planning a pregnancy [PDF]
РМЖ. Мать и дитя, 2018 Treatment of recurrent vulvovaginal candidiasis in women planning a pregnancy Borovikov I.O., Kutsenko I.I., Gerasimenko E.E. Kuban State Medical University, Krasnodar Aim: evaluation of treatment methods for recurrent vulvovaginal candidiasis ...
Borovikov I.O. +2 more
doaj
Pathogenetic aspects and modern possibilities of therapy of vulvovaginal candidiasis [PDF]
Vestnik Dermatologii i VenerologiiThe literature review presents modern aspects of the etiology and pathogenesis of vulvovaginal candidiasis, highlights issues of immunological resistance and the significance of polymorphic and pathological gene loci, the functioning of which leads to ...
Margarita R. Rakhmatulina +2 more
doaj +1 more source
Heparan Sulfate Proteoglycans in Immunity
Proteoglycan Research, Volume 4, Issue 2, April 2026.ABSTRACT In immune cells, heparin was first identified in mast cells in the 1940s, followed by the discovery of heparan sulfate in lymphocytes and granulocytes during the 1970s and 1980s. Subsequent decades of research have revealed how heparan sulfate and heparin, conjugated to core proteins as heparan sulfate proteoglycans (HSPGs), act as versatile ...
Moe Iwai, Pyong Woo Park
wiley +1 more source
, 2015 Introducción: la infección por Cándida es la segunda causa de consulta al ginecólogo después de la vulvovaginitis bacteriana. Las causas son multifactoriales.
Sacoto Ullauri, Gustavo Eugenio
core
Evidence‐ and consensus‐based guideline on lichen sclerosus
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 4, Page 566-584, April 2026.Summary The German‐language, consensus‐ and evidence‐based S3 guideline on lichen sclerosus (LS) was developed based on the European “EuroGuiDerm Guideline on lichen sclerosus” under the leadership of the German Dermatological Society (DDG) and the German Society for Gynecology and Obstetrics (DGGG).
Gudula Kirtschig +25 more
wiley +1 more source
Mannose-binding lectin gene polymorphism, vulvovaginal candidiasis, and bacterial vaginosis
, 2015 OBJECTIVE: To evaluate associations between polymorphisms in the gene coding for mannose-binding lectin (MBL) and the diagnosis of acute or recurrent vulvovaginal candidiasis and bacterial vaginosis METHODS: Women at two outpatient clinics in Brazil ...
Giraldo, PC +6 more
core +1 more source